MedTrace Logo

Apitoxin Versus Soft Laser for Management of Aphthous Ulceration.

NCT07135609 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2025-08-22

No results posted yet for this study

Summary

The current study evaluated the clinical effect and outcome of locally applied bee venom versus low-level laser therapy (LLLT) for the treatment of recurrent aphthous ulceration.

Conditions

  • Apitoxin
  • Bee Venom Therapy
  • Management
  • Aphthous Ulceration

Interventions

DEVICE

Low-level laser therapy (LLLT)

Patients managed by Low-level laser therapy (LLLT).

DRUG

Apitoxin

Patients managed with 0.3% Apitoxin Gel.

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-30
Primary Completion
2025-02-02
Completion
2025-02-02

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07135609 on ClinicalTrials.gov